NXP Semiconductors Selects AWS as Its Preferred Cloud Provider to Power Electronic Design Automation in the Cloud
Today, Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that NXP Semiconductors N.V. has selected AWS as its preferred cloud provider and is migrating the vast majority of its electronic design automation (EDA) workloads from NXP data centers to AWS. Running on the world’s leading cloud extends NXP’s efficiency and competitive edge in the design and verification of advanced semiconductors tailored to the requirements of automotive, industrial Internet of Things (IoT), mobile, and communications infrastructure businesses. The Netherlands-based company uses AWS’s proven global infrastructure and capabilities in high performance computing (HPC), storage, analytics, and machine learning to enhance collaboration and EDA throughput across dozens of its worldwide design centers, as well as to reduce costs with elastic scaling of compute resources and minimize scheduling risks for design projects. In addition, thanks to AWS’s virtually unlimited scale, NXP engineers gain more time to focus on innovation rather than managing compute resources.
Running on AWS, NXP aims to achieve long-term process improvements that transform how semiconductors are designed and tested. Before NXP can manufacture new chips, its designs undergo extensive testing and validation through the EDA process to ensure they are functionally safe, secure, high quality, and highly performant. NXP’s complex EDA workflows include front-end design, performance simulation, and verification, along with backend workloads that include timing and power analysis, design rule checks, and other applications to prepare a chip for production. Historically, semiconductor companies run these highly iterative workflows from on-premises data centers with fixed compute capacity. However, because of the massive compute power involved for each cycle and the increasing complexity of chip designs, producing a new device can take many months or even years unless the companies accurately forecast and install additional compute infrastructure. In contrast, by powering its EDA with AWS, NXP gains the scale and agility to advance multiple projects at the same time on demand, regardless of their complexity, and run dozens of performance simulations in parallel to accelerate time to result.
To better manage the scale and complexity of its design activities, NXP relies on AWS analytics and machine learning services to continuously refine its research and development workflows. NXP uses Amazon QuickSight (AWS’s machine learning-powered business intelligence service built for the cloud) to generate more powerful engineering and operational insights that help increase workflow efficiency. For example, by rapidly translating results from one step of testing into modifications for another, NXP can reduce the time required to iterate chip designs. NXP also uses Amazon SageMaker (AWS’s service that helps developers and data scientists build, train, and deploy machine learning models quickly in the cloud and at the edge) to optimize how it structures compute, storage, and third-party software application licenses. To support this work, NXP is building a data lake on AWS using Amazon Simple Storage Service (Amazon S3) and AWS Glue (AWS’s service for simply and cost-effectively extracting, transforming, and loading data).
In addition, NXP takes advantage of AWS’s range of specialized instances for HPC to further streamline its EDA workflows. The selection of instance types allows NXP to meet the unique requirements of each design project while also achieving a high degree of price performance. NXP uses Amazon FSx for Lustre (AWS’s service that provides cost-effective, high-performance, scalable storage for compute workloads like EDA) to store petabytes of design simulation data and make it quickly available for analysis.
“We believe cloud-based EDA is critical to accelerating semiconductor innovation and getting new designs to market faster to power an increasingly digital world where more and more devices and infrastructure are connected. AWS gives us the best scale, global presence, and selection of compute and storage options, with continuous improvements in price performance, that we need,” said Olli Hyyppa, CIO and senior vice president, NXP Semiconductors N.V. “We’re excited to expand our relationship with AWS to power the next generation of EDA workloads in the cloud. This will give precious time back to our design engineers to focus on innovation and lead the transformation of the semiconductor industry.”
“At AWS, we consider ourselves to be a community of builders, and this engagement with NXP reinforces what’s possible when you free builders to work in the best environments, with the infrastructure and capabilities they need,” said Dave Brown, vice president of Amazon Elastic Compute Cloud, Amazon Web Services, Inc. “By shifting their EDA workloads to AWS, NXP designers will have access to the best tools available for collaborating on semiconductor design and development around the world. This move will help NXP produce chips that power innovation in IoT, connected cars, and more. We’re proud to support a leading driver of innovation in the semiconductor industry, and we look forward to seeing what becomes possible when chip design moves to the cloud at such a large scale.”
About Amazon Web Services
For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud offering. AWS has been continually expanding its services to support virtually any cloud workload, and it now has more than 200 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 81 Availability Zones within 25 geographic regions, with announced plans for 24 more Availability Zones and eight more AWS Regions in Australia, India, Indonesia, Israel, New Zealand, Spain, Switzerland, and the United Arab Emirates. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
About NXP Semiconductors
NXP Semiconductors N.V. (NASDAQ: NXPI) enables secure connections for a smarter world, advancing solutions that make lives easier, better, and safer. As the world leader in secure connectivity solutions for embedded applications, NXP is driving innovation in the automotive, industrial & IoT, mobile, and communication infrastructure markets. Built on more than 60 years of combined experience and expertise, the company has approximately 29,000 employees in more than 30 countries and posted revenue of $8.61 billion in 2020. Find out more at www.nxp.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
X-Chem Acquires ComInnex25.10.2021 21:00:00 EEST | Press release
X-Chem, the pioneer of DNA-encoded library (DEL) technology and recognized leader in generating actionable results to drive small molecule drug discovery, today announced the acquisition of ComInnex, a leading European provider of synthetic chemistry services and novel chemical technologies to support early-stage drug discovery. With demand for high-quality discovery services increasing across the world, this complementary pairing of a North American leader in DEL and medicinal chemistry with a European leader in synthetic chemistry and custom DEL services delivers the capacity, footprint and expertise to better serve the demands of customers in a global market. “As a united company, with an increased global presence, we are positioned to meet the increasing demand for innovative chemistry solutions and high-quality discovery services worldwide,” noted Matt Clark, Ph.D., CEO of X-Chem. “The acquisition of ComInnex further extends X-Chem’s expertise and scale of DEL services to help bio
European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-1925.10.2021 17:30:00 EEST | Press release
Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced the European Commission identified lenzilumab as one of the “10 most promising treatments for COVID-19” in a report and press release issued on October 22, 2021.1,2 “We are gratified the European Commission has recognized the potential of lenzilumab to offer an important treatment option for patients hospitalized with COVID-19,” said Cameron Durrant, MD, Chairman and CEO, Humanigen. “We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19. We are also progressing with our early access program, under compassionate use, where allowed by regulations in some European countries and the United States.” *Lenzilumab is not authorized, or approved
Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 202125.10.2021 15:00:00 EEST | Press release
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced the results of two key retrospective analyses at the American College of Gastroenterology 2021 annual congress. One analysis evaluated the safety and efficacy of investigational RBX2660 among a broad cohort of CDI patients with comorbidities commonly found in patients with CDI, and was recognized with a Presidential Poster Award for high-quality, novel, unique and interesting research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005099/en/ Ferring Fact Sheet While the eligibility criteria in prospective clinical trials often are narrowly defined to include patients diagnosed with only CDI, this analysis allowed researchers to evaluate the impact of RBX2660 in a patient population that is more reflective of a real-world setting. In the analysis, 94 participants with comorbid conditions commonly found in people with recurrent CDI (rCDI) were trea
Study Finds Overwhelming Evidence That Color Blindness Hinders Learning in School, Reports EnChroma25.10.2021 15:00:00 EEST | Press release
EnChroma – creators of glasses for color blindness – today released the results of a landmark study that clearly demonstrates the negative effect color blindness has on learning for millions of students. The data strongly indicates that schools are failing to identify color blind students and that parents, educators and legislators need to better support these students. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005173/en/ Standard Color Vision and Color Blind View @EnChroma In early 2020, nearly 1,000 color blind people, including the parents of color blind children, shared their opinions about how Color Vision Deficiency (CVD) affected their educational experiences. Seventy-eight percent said they were often frustrated or confused by colors in school assignments and activities. One in three say color blindness affected their confidence in school, and 30% felt like they might be a “slow learner” before discovering
Rockefeller Capital Management to Open First International Office in London with the Formation of Rockefeller Asset Management International25.10.2021 15:00:00 EEST | Press release
Rockefeller Asset Management (RAM), a division of Rockefeller Capital Management, with a long track record of investing in global equities and ESG investing has announced the formation of Rockefeller Asset Management International, to expand its European market presence. The initial plans for expansion include opening an office in London, to better serve clients across the UK, Europe, and Asia. “Our Asset Management business has generated real momentum across Europe and we are excited to continue to serve our international clients with a full suite of sustainable investment products and a growing local presence,” said Greg Fleming, CEO and President of Rockefeller Capital Management. RAM, which was recently awarded the 2021 Principles for Responsible Investing (PRI) award for “ESG incorporation initiative of the year,” has seen strong growth in Europe. Over the last two years, the business, which surpassed $2.5 billion in assets from European investors, launched a UCITS ICAV, an Irelan
CAPRISA and Evotec Launch New Project to Fast-Track New Technology for HIV Prevention25.10.2021 14:53:00 EEST | Press release
Today, at a side meeting during the AU-EU Ministerial Summit in Kigali, Rwanda, Prof Salim Abdool Karim, Director of CAPRISA, announced a collaboration with a leading life science company Evotec for the designing and development of CAP256, a broadly neutralizing antibody against HIV. The project is a major expansion of the development of an antibody originally developed jointly by CAPRISA and the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases of the US NIH. This new project is a major boost for the CAP256 antibody as a potential tool in the fight against HIV in Africa and showcases the potential of African researchers to fight the continent’s high-burden diseases. The principal aim of the new joint project is to change the course of the HIV epidemic in Africa, which has 70% of the global HIV burden. CAP256, isolated from a South African woman by CAPRISA and the VRC, has demonstrated a good safety profile in Phase I studies. The next step is t
Everbridge Awarded Contract to Power Countrywide Public Warning System in The Netherlands25.10.2021 14:30:00 EEST | Press release
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced that the Netherlands selected the company’s end-to-end countrywide Public Warning solution to help keep its residents and visitors safe and informed in the event of an emergency. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005296/en/ Everbridge Awarded Contract to Power Countrywide Public Warning System in The Netherlands (Photo: Business Wire) One of the most densely populated regions in Europe, 17.5 million residents call the Netherlands home, and millions of tourists visit the coastal country each year. Powered by Everbridge, NL-Alert can reach 94 percent of the Dutch population on their mobile phones, along with digital signage at bus, train, tram, and metro stations across the country. The Netherlands will leverage Everbridge’s next-generation, end-to-end Public Warning solution, featuring a unique multi-chann
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom